Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IAE-0972 by Sunho (China) Biopharmaceutical for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
IAE-0972 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Squamous Non-Small Cell Lung Cancer....
IAE-0972 by Sunho (China) Biopharmaceutical for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
IAE-0972 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Cutaneous Squamous Cell Carcinoma (cSCC)....
IAE-0972 by Sunho (China) Biopharmaceutical for Metastatic Colorectal Cancer: Likelihood of Approval
IAE-0972 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Metastatic Colorectal Cancer. According to...
IAE-0972 by Sunho (China) Biopharmaceutical for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
IAE-0972 is under clinical development by Sunho (China) Biopharmaceutical and currently in Phase II for Recurrent Head And Neck Squamous...